Additionally, a closer highlight on TIM-3 and VISTA roles in IPF indicates that inhibitory checkpoints might play opposite roles in IPF and, therefore, targeting these receptors requires different strategies between inhibition and agonistic activation. This evidence concerns the gene VSIR and idiopathic pulmonary fibrosis.